Virologic response and haematologic toxicity of boceprevir‐ and telaprevir‐containing regimens in actual clinical settings

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|9|691-700

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.9, 2015-09, pp. : 691-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 1002-1010

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nevirapine-Based Regimens in Routine Clinical Settings: Results from a Large Italian Cohort of HIV-1 Infected Adults

By  

Current Drug Safety, Vol. 6, Iss. 3, 2011-07 ,pp. : 138-144

Bentham Science Publishers

Access to resources Recommend Favorite

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 671-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1‐coinfected patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2090-2099

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug–drug interactions of telaprevir and boceprevir in HCV‐monoinfected and HIV/HCV‐coinfected patients can modify the adherence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1557-1565

John Wiley & Sons Inc

Access to resources Recommend Favorite